Cargando…

The atypical anxiolytic drug, tofisopam, selectively blocks phosphodiesterase isoenzymes and is active in the mouse model of negative symptoms of psychosis

Tofisopam is a member of the 2,3-benzodiazepine compound family which is marketed for the treatment of anxiety in some European countries. In contrast to classical 1,4-benzodiazepines, the compound does not bind to the benzodiazepine binding site of the γ-aminobutyric acid receptor and its psychopha...

Descripción completa

Detalles Bibliográficos
Autores principales: Rundfeldt, Chris, Socała, Katarzyna, Wlaź, Piotr
Formato: Texto
Lenguaje:English
Publicado: Springer Vienna 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993883/
https://www.ncbi.nlm.nih.gov/pubmed/20967473
http://dx.doi.org/10.1007/s00702-010-0507-3